Ripped from the Headlines: Townhall on Recent Controversies in Rx Drug Advertising and Promotion

January 31, 2020 8:30am

Mark Gaydos
VP & Head, NA General Med. & Established Products / US Ad-Promo
Sanofi

Dara Katcher Levy
Director
Hyman, Phelps & McNamara, P.C.

  • Analysing the evolution of direct-to-consumer advertisements of Rx Drugs
  • Examining promotional efforts surrounding the advertising and labelling requirements for controlled substances, i.e., Epidiolex
  • Understanding how the ongoing debate over the inclusion of drug pricing in television advertisements would have affected messaging
  • Determining how recently issued warning letters surrounding advertising and promotional amendment concerns